385
Views
33
CrossRef citations to date
0
Altmetric
Reviews

Adoptive cell therapy against EBV-related malignancies: a survey of clinical results

, , PhD, , MD, , PhD, , MD & , MD PhD
Pages 1265-1294 | Published online: 11 Aug 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Raymund R Razonable. (2011) Management of viral infections in solid organ transplant recipients. Expert Review of Anti-infective Therapy 9:6, pages 685-700.
Read now
Kewal K Jain. (2010) Personalized cancer vaccines. Expert Opinion on Biological Therapy 10:12, pages 1637-1647.
Read now
Holbrook Kohrt, Mark Lee & Ranjana Advani. (2010) Risk stratification in extranodal natural killer/T-cell lymphoma. Expert Review of Anticancer Therapy 10:9, pages 1395-1405.
Read now
Debora Martorelli, Elena Muraro, Anna Merlo, Riccardo Turrini, Antonio Rosato & Riccardo Dolcetti. (2010) Role of CD4+ Cytotoxic T Lymphocytes in the Control of Viral Diseases and Cancer. International Reviews of Immunology 29:4, pages 371-402.
Read now
Jennifer A Westwood, Linda J Berry, Leanne XJ Wang, Connie PM Duong, Hollie J Pegram, Phillip K Darcy & Michael H Kershaw. (2010) Enhancing adoptive immunotherapy of cancer. Expert Opinion on Biological Therapy 10:4, pages 531-545.
Read now
Holbrook Kohrt & Ranjana Advani. (2009) Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment. Leukemia & Lymphoma 50:11, pages 1773-1784.
Read now

Articles from other publishers (27)

Maja Stanojevic, Alice Bertaina, Carmem Bonfim, Rachele Ciccocioppo, Sandra Cohen, Duncan Purtill, Annalisa Ruggeri, Athena Russell, Akshay Sharma, Robert Wynn, Jaap Jan Boelens, Susan Prockop & Allistair Abraham. (2022) Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatment. Cytotherapy 24:9, pages 884-891.
Crossref
Angela Kwok-Fung Lo, Christopher W. Dawson, Hong Lok Lung, Ka-Leung Wong & Lawrence S. Young. (2021) The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy. Frontiers in Oncology 11.
Crossref
Kewal K. JainKewal K. Jain. 2021. Textbook of Personalized Medicine. Textbook of Personalized Medicine 479 508 .
Angela Kwok-Fung Lo, Christopher W. Dawson, Hong Lok Lung, Ka-Leung Wong & Lawrence S. Young. (2020) The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies. Cancers 12:7, pages 1940.
Crossref
Richard J. O’Reilly, Susan Prockop, Aisha Hasan & Ekaterina Doubrovina. (2019) Therapeutic advantages provided by banked virus-specific T-cells of defined HLA-restriction. Bone Marrow Transplantation 54:S2, pages 759-764.
Crossref
Nayoun Kim, Hyun-Jung Sohn, Joo Hyun Oh, Young-Woo Jeon, Hyun-Joo Lee, Hyun-Il Cho, Byung Ha Chung, Chul-Woo Yang, Tai-Gyu Kim & Seok-Goo Cho. (2017) Infusions of Epstein–Barr virus-specific cytotoxic T lymphocytes as post-remission therapy in high-risk post-transplant lymphoproliferative disorder patients: report of two cases. International Journal of Hematology 107:5, pages 596-603.
Crossref
Luis Carlos Veloza, Mauricio Collazos, Nury Olaya, Sandra Salas, Adriana Corredor, H Diez, I. Castellanos & Maria Gutierrez. (2017) Presencia del marcador lmp-1 del virus epstein barr en linfomas de caninos. Revista de la Facultad de Medicina Veterinaria y de Zootecnia 64:3.
Crossref
R J O'Reilly, S Prockop, A N Hasan, G Koehne & E Doubrovina. (2016) Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections. Bone Marrow Transplantation 51:9, pages 1163-1172.
Crossref
Damiana Antonia Faè, Debora Martorelli, Katy Mastorci, Elena Muraro, Jessica Dal Col, Giovanni Franchin, Luigi Barzan, Elisa Comaro, Emanuela Vaccher, Antonio Rosato & Riccardo Dolcetti. (2016) Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma Immunotherapy. Cancer Immunology Research 4:5, pages 431-440.
Crossref
Julie Orio, Cédric Carli, Valérie Janelle, Martin Giroux, Julie Taillefer, Mathieu Goupil, Manon Richaud, Denis-Claude Roy & Jean-Sébastien Delisle. (2015) Early exposure to interleukin-21 limits rapidly generated anti–Epstein-Barr virus T-cell line differentiation. Cytotherapy 17:4, pages 496-508.
Crossref
Kewal K. JainKewal K. Jain. 2015. Textbook of Personalized Medicine. Textbook of Personalized Medicine 199 381 .
Kewal K. JainKewal K. Jain. 2014. Applications of Biotechnology in Oncology. Applications of Biotechnology in Oncology 347 370 .
Kewal K. JainKewal K. Jain. 2014. Applications of Biotechnology in Oncology. Applications of Biotechnology in Oncology 671 824 .
Vanya IchevaSimone KayserDaniel WolffSebastian TuveChristina KyzirakosWolfgang BethgeJohann GreilMichael H. AlbertWolfgang SchwingerMichaela NathrathMichael SchummStefan StevanovicRupert HandgretingerPeter LangTobias Feuchtinger. (2013) Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation. Journal of Clinical Oncology 31:1, pages 39-48.
Crossref
Olivia Hatton, Olivia M. Martinez & Carlos O. Esquivel. (2012) Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder. Pediatric Transplantation 16:3, pages 220-229.
Crossref
Ekaterina DoubrovinaBanu Oflaz-SozmenSusan E. ProckopNancy A. KernanSara AbramsonJulie Teruya-FeldsteinCyrus HedvatJoanne F. Chou, Glenn Heller, Juliet N. Barker, Farid BouladHugo Castro-Malaspina, Diane GeorgeAnn Jakubowski, Guenther Koehne, Esperanza B. Papadopoulos, Andromachi ScaradavouTrudy N. SmallRamzi KhalafJames W. Young & Richard J. O'Reilly. (2012) Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. Blood 119:11, pages 2644-2656.
Crossref
Kenneth P. Micklethwaite, Helen E. Heslop & Malcolm K. Brenner. 2012. Innate Immune Regulation and Cancer Immunotherapy. Innate Immune Regulation and Cancer Immunotherapy 415 438 .
Barbara C. G�rtner. 2011. Manual of Clinical Microbiology. Manual of Clinical Microbiology 1575 1584 .
A John Barrett & J Joseph Melenhorst. (2011) Is Human Cell Therapy Research Caught in a Mousetrap?. Molecular Therapy 19:2, pages 224-227.
Crossref
Qian WangHongxing LiuXian ZhangQian LiuYanping Xing, Xiaoge Zhou, Chunrong TongPing Zhu. (2010) High doses of mother's lymphocyte infusion to treat EBV-positive T-cell lymphoproliferative disorders in childhood. Blood 116:26, pages 5941-5947.
Crossref
Mathilde Berthomé, Géraldine Gallot, Régine Vivien, Béatrice Clémenceau, Jean-Michel Nguyen, Marianne Coste-Burel & Henri Vié. (2010) Viral DNA contamination is responsible for Epstein–Barr virus detection in cytotoxic T lymphocytes stimulated in vitro with Epstein–Barr virus B-lymphoblastoid cell line. Cancer Immunology, Immunotherapy 59:12, pages 1867-1875.
Crossref
K. Mucha, B. Foroncewicz, B. Ziarkiewicz-Wroblewska, M. Krawczyk, J. Lerut & L. Paczek. (2010) Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?. Nephrology Dialysis Transplantation 25:7, pages 2089-2098.
Crossref
Jean-Pierre Droz, Isabelle Ray-Coquard & Jean-Louis PeixAurélien Marabelle & Thierry Philip. 2010. Tumeurs malignes rares. Tumeurs malignes rares 107 115 .
Dan Jones. 2010. Neoplastic Hematopathology. Neoplastic Hematopathology 391 412 .
Lucie Kalinova, Jarmila Indrakova & Petr Bachleda. (2009) POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER. Biomedical Papers 153:4, pages 251-257.
Crossref
Jennifer Brewin, Christoph Mancao, Karin Straathof, Helen Karlsson, Sujith Samarasinghe, Persis J. Amrolia & Martin Pule. (2009) Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. Blood 114:23, pages 4792-4803.
Crossref
Manuel N. Fernández. (2009) Improving the outcome of cord blood transplantation: use of mobilized HSC and other cells from third party donors. British Journal of Haematology 147:2, pages 161-176.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.